CD20-Targeted α-Radionuclides Synergize with Immune Checkpoint Inhibition to Treat Murine Lymphoma.
Saved in:
| Title: | CD20-Targeted α-Radionuclides Synergize with Immune Checkpoint Inhibition to Treat Murine Lymphoma. |
|---|---|
| Authors: | O'Steen S; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington; sosteen@fredhutch.org damiangreen@miami.edu., Lee SY; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington., Comstock ML; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington., Kehret AR; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington., Lin Y; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington., Hamlin DK; Department of Radiation Oncology, University of Washington, Seattle, Washington., Dexter SL; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington., Hippe DS; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; and., Gooley TA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; and., Wilbur DS; Department of Radiation Oncology, University of Washington, Seattle, Washington., Li Y; Department of Radiation Oncology, University of Washington, Seattle, Washington., Walter RB; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; and.; School of Medicine, University of Washington, Seattle, Washington., Till B; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; and.; School of Medicine, University of Washington, Seattle, Washington., Orozco JJ; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington.; School of Medicine, University of Washington, Seattle, Washington., Green DJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; and sosteen@fredhutch.org damiangreen@miami.edu.; School of Medicine, University of Washington, Seattle, Washington. |
| Source: | Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2026 May 01; Vol. 67 (5), pp. 693-699. Date of Electronic Publication: 2026 May 01. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. |
| Journal Info: | Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41644291 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: CD20-Targeted α-Radionuclides Synergize with Immune Checkpoint Inhibition to Treat Murine Lymphoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22O'Steen+S%22">O'Steen S</searchLink>; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington; sosteen@fredhutch.org damiangreen@miami.edu.<br /><searchLink fieldCode="AU" term="%22Lee+SY%22">Lee SY</searchLink>; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Comstock+ML%22">Comstock ML</searchLink>; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Kehret+AR%22">Kehret AR</searchLink>; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Lin+Y%22">Lin Y</searchLink>; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Hamlin+DK%22">Hamlin DK</searchLink>; Department of Radiation Oncology, University of Washington, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Dexter+SL%22">Dexter SL</searchLink>; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Hippe+DS%22">Hippe DS</searchLink>; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; and.<br /><searchLink fieldCode="AU" term="%22Gooley+TA%22">Gooley TA</searchLink>; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; and.<br /><searchLink fieldCode="AU" term="%22Wilbur+DS%22">Wilbur DS</searchLink>; Department of Radiation Oncology, University of Washington, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Li+Y%22">Li Y</searchLink>; Department of Radiation Oncology, University of Washington, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Walter+RB%22">Walter RB</searchLink>; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; and.; School of Medicine, University of Washington, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Till+B%22">Till B</searchLink>; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; and.; School of Medicine, University of Washington, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Orozco+JJ%22">Orozco JJ</searchLink>; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington.; School of Medicine, University of Washington, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Green+DJ%22">Green DJ</searchLink>; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; and sosteen@fredhutch.org damiangreen@miami.edu.; School of Medicine, University of Washington, Seattle, Washington. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220217410%22">Journal of nuclear medicine : official publication, Society of Nuclear Medicine</searchLink> [J Nucl Med] 2026 May 01; Vol. 67 (5), pp. 693-699. <i>Date of Electronic Publication: </i>2026 May 01. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Society+of+Nuclear+Medicine%22">Society of Nuclear Medicine </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0217410 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1535-5667 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201615505%22">01615505 </searchLink><i>NLM ISO Abbreviation: </i>J Nucl Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41644291 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.2967/jnumed.125.270515 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 693 Titles: – TitleFull: CD20-Targeted α-Radionuclides Synergize with Immune Checkpoint Inhibition to Treat Murine Lymphoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: O'Steen S – PersonEntity: Name: NameFull: Lee SY – PersonEntity: Name: NameFull: Comstock ML – PersonEntity: Name: NameFull: Kehret AR – PersonEntity: Name: NameFull: Lin Y – PersonEntity: Name: NameFull: Hamlin DK – PersonEntity: Name: NameFull: Dexter SL – PersonEntity: Name: NameFull: Hippe DS – PersonEntity: Name: NameFull: Gooley TA – PersonEntity: Name: NameFull: Wilbur DS – PersonEntity: Name: NameFull: Li Y – PersonEntity: Name: NameFull: Walter RB – PersonEntity: Name: NameFull: Till B – PersonEntity: Name: NameFull: Orozco JJ – PersonEntity: Name: NameFull: Green DJ IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2026 May 01 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1535-5667 Numbering: – Type: volume Value: 67 – Type: issue Value: 5 Titles: – TitleFull: Journal of nuclear medicine : official publication, Society of Nuclear Medicine Type: main |
| ResultId | 1 |